Staminol Rapid Surge
Staminol Rapid Surge by GNC Men's is a Pre-Workout supplement classified as an 'Other Combinations' type, earning a good N+ Score of 82 and a 'B' grade. This product contains 7 ingredients, providing Niacin at a clinically studied dose of 25 mg. Other active ingredients include a Sexual Health Circulatory Blend at 300 mg, Yohimbe bark extract at 112.5 mg, and Caffeine Anhydrous at 100 mg. The formulation also includes Ginkgo biloba leaf extract at 50 mg and ReVida(R) trans-Resveratrol at 30 mg. This product may be considered by individuals looking for a pre-workout option with specific stimulant and circulatory support ingredients.
About This Product
Staminol Rapid Surge by GNC Men's is a pre-workout supplement containing 7 active ingredients. It has earned an N+ Score of 82/100 (Grade B).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Niacin.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Niacin | 25.000 mg | Optimal |
| Dehydroepiandrosterone | 25.000 mg | N/A |
| Yohimbe bark extract | 112.500 mg | N/A |
| Caffeine Anhydrous | 100.000 mg | N/A |
| Ginkgo biloba leaf extract | 50.000 mg | N/A |
| Sexual Health Circulatory Blend | 300.000 mg | N/A |
| ReVida(R) trans-Resveratrol | 30.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.